Despite Erratic Quality-Control Results, Theranos Continued To Run Blood Tests
Inaccurate results from the test can be especially serious for patients taking blood thinners such as warfarin.
The Wall Street Journal:
Theranos Ran Tests Despite Quality Problems
A federal inspection report said a Theranos Inc. laboratory ran an important blood test on 81 patients in a six-month period despite erratic results from quality-control checks meant to ensure the test’s accuracy, people familiar with the report said. The report hasn’t been publicly released but is far more detailed than the letter that summarized the results of last fall’s inspection of the Newark, Calif., lab by the federal Centers for Medicare and Medicaid Services and was sent to Theranos in late January, these people said. (Carreyrou and Weaver, 3/7)